New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine
- PMID: 28795399
- PMCID: PMC5706548
- DOI: 10.1002/cpt.755
New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine
Abstract
The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.
© 2017 American Society for Clinical Pharmacology and Therapeutics.
Figures
References
MeSH terms
Grants and funding
- R24 GM061374/GM/NIGMS NIH HHS/United States
- P50 GM115318/GM/NIGMS NIH HHS/United States
- R24 GM115264/GM/NIGMS NIH HHS/United States
- R24 GM115277/GM/NIGMS NIH HHS/United States
- U24 GM115370/GM/NIGMS NIH HHS/United States
- R01 GM109110/GM/NIGMS NIH HHS/United States
- R24 GM119977/GM/NIGMS NIH HHS/United States
- UL1 TR001427/TR/NCATS NIH HHS/United States
- UC4 DK104194/DK/NIDDK NIH HHS/United States
- P30 DK098722/DK/NIDDK NIH HHS/United States
- U01 GM061374/GM/NIGMS NIH HHS/United States
- P50 GM115305/GM/NIGMS NIH HHS/United States
- P50 GM115279/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
